CDC Immunizations Information Systems (IIS) Vaccine Code Set Release Notes

• Registry (IIS): CVX - Vaccines Administered Code Set
• Registry (IIS): Mapping CVX to Vaccine Groups
• Registry (IIS): MVX - Manufacturers of Vaccines Code Set
• Registry (IIS): Mapping Product Names to CVX and MVX (Tradenames)
• Registry (IIS): Mapping NDC to CVX/MVX
• Registry (IIS): Current NDC Table Access
• Registry (IIS): CPT[TM] Codes Mapped to CVX Codes

Web Services Publication Date: September 13, 2019

The individual filenames included in this distribution contain the publication date (20190913)

Release Notes: This release does not include updates for Vaccine Information Statement (VIS) codes and maps. A separate set of release notes and files are prepared for VIS code updates and will be distributed in a separate release cycle. 

General Note regarding this release: Codes with “Last Update” dates after September 2, 2019 reflect changes and additions in this release and include the following code set updates:

1) CVX/ Vaccine Group Code Updates:

• New Vaccine Group Added: DENGUE 
• CVX Code 56 “dengue fever vaccine” status changed from “Never Active” to “Active” and mapped to the new Vaccine Group “DENGUE”.

2) CDC Product Tradename/CVX/MVX Table Updates:

• Product Added: A new product, “DENGVAXIA”, has been added to represent this new tetravalent vaccine. It is mapped to MVX – “PMC” (Sanofi Pasteur), and CVX 56 “dengue fever vaccine”.

3) NDC Code Updates:

• The following NDCs have been added:

Sale Proprietary Name	Sale Labeler	Sale NDC11	Use NDC11
FluMist Quadrivalent	MedImmune, LLC	66019-0306-10	66019-0306-01
DENGVAXIA	Sanofi Pasteur	49281-0605-01	49281-0606-58*

*It should be noted that DENGVAXIA is provided in a kit. The Unit of Use listed above contains the antigen, a second NDC, 49281-0549-58 is included in the kit but is a saline diluent that is not included in the CDC code set NDCs listed.

• The following NDCs have been retired:

Sale Proprietary Name	Sale Labeler	Sale NDC11	Use NDC11
ENGERIX-B	GlaxoSmithKline Biologicals SA	58160-0820-11	58160-0820-01
FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)	Seqirus, Inc.	70461-0318-03	70461-0318-04

Note: The two NDCs for FLUCELVAX QUADRIVALENT (above) were incorrectly listed in the previous release notes as new vaccines. They should have been listed in the table of retired NDCs.